Companies: 10,795·Total market cap: $144.5T
STERIS plc

STERIS plc

STENYSEHealthcare● Active
$210.85
$-1.50(-0.71%)
Market Cap$20.6B
P/E Ratio
52W High$269.44
52W Low$195.14

STERIS plc (STE) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

STE · cash on hand · updated Mar 31, 2026

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$439.6M +156.0% vs prior year
FY · as of Mar 31, 2026 · Reported in USD
Cash & Cash Equiv. (CCE)
$439.6M
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
+156.0%
vs prior fiscal year
Latest Quarter
$439.6M
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: March 31, 2026

Net cash vs debt

Cash & ST Investments$439.6MCash on Hand
Total Debt$2.09BTotal Debt
Net Cash / Net Debt−$1.65BNet Debt Position
Cash vs Debt Ratio
Cash 17%Debt 83%

STERIS plc carries a net debt position of $1.65B. Total debt ($2.09B) exceeds cash on hand ($439.6M). STERIS plc cash vs debt ratio: 17% cash / 83% debt.

Net Cash = Cash & ST Investments − Total Debt$439.6M$2.09B = −$1.65B

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
STE annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Mar 31, 2026Latest$439.6M+156.0%
Mar 31, 2025$171.7M-17.1%
Mar 31, 2024$207.0M-0.6%
Mar 31, 2023$208.4M-40.2%
Mar 31, 2022$348.3M+57.9%
STE cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.7%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%
#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
STERIS plc
STERIS plcYOU
STE
$439.6M2.1%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

STERIS plc (STE) cash on hand as of March 31, 2026 is $439.6M, comprising $439.6M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as STERIS plc cash and short-term investments on the balance sheet (10-K filing). Also referred to as STERIS plc cash reserves or cash position.

STERIS plc annual cash on hand history shows increased +156.0% in 2026: increased +156.0% in 2026. STERIS plc cash reserves in 2026 reflect the company's capital allocation strategy.

STERIS plc carries total debt of $2.09B against cash of $439.6M, resulting in a net debt position of -$1.65B. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Frequently asked questions

STE cash on hand · 5 questions

As of March 31, 2026, STERIS plc (STE) has $439,600,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $439,600,000 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $439,600,000. Data sourced from the annual 10-K filing via FMP.

STE cash on handSTE cash reservesSTE cash 2026how much cash does STE have

Source: FMP /balance-sheet-statement · US GAAP · STERIS plc · STERIS plc SEC 10-K & 10-Q filings · US GAAP · Last updated: March 31, 2026